Lutzker Stuart
SEC insider (Form 3/4/5 filer). CIK 0002009257. President of R&D at ArriVent BioPharma, Inc. (AVBP). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 2, 2026. Located in NEWTOWN SQUARE, PA.
Companies Lutzker Stuart has filed insider reports for
- ArriVent BioPharma, Inc. (AVBP): Director, Officer, President of R&D
Lutzker Stuart
CIK: 0002009257
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AVBP
ArriVent BioPharma, Inc.
DirectorOfficer